Global Refrigerant Market 2017 Share, Trend, Segmentation and Forecast to 2022

Wiseguyreports.Com Adds “Refrigerant – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 To 2022”

PUNE, INDIA, May 22, 2017 /EINPresswire.com/ —

Summary

In this report, we analyze the Refrigerant industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a prediction of its production and consumption in coming 2017-2022.
At the same time, we classify different Refrigerant based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Refrigerant industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1294664-global-refrigerant-industry-market-research-2017

The report can answer the following questions:
1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Refrigerant?
2. Who are the global key manufacturers of Refrigerant industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?
3. What are the types and applications of Refrigerant? What is the market share of each type and application?
4. What are the upstream raw materials and manufacturing equipment of Refrigerant? What is the manufacturing process of Refrigerant?
5. Economic impact on Refrigerant industry and development trend of Refrigerant industry.
6. What will the Refrigerant market size and the growth rate be in 2022?
7. What are the key factors driving the global Refrigerant industry?
8. What are the key market trends impacting the growth of the Refrigerant market?
9. What are the Refrigerant market challenges to market growth?
10. What are the Refrigerant market opportunities and threats faced by the vendors in the global Refrigerant market?

Objective of Studies:
1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Refrigerant market.
2. To provide insights about factors affecting the market growth. To analyze the Refrigerant market based on various factors- price analysis, supply chain analysis, porte five force analysis etc.
3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.
4. To provide country level analysis of the market with respect to the current market size and future prospective.
5. To provide country level analysis of the market for segment by application, product type and sub-segments.
6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Refrigerant market.

At any Query @ https://www.wiseguyreports.com/enquiry/1294664-global-refrigerant-industry-market-research-2017

Table of Contents

1 Industry Overview of Refrigerant

1.1 Brief Introduction of Refrigerant

1.1.1 Definition of Refrigerant

1.1.2 Development of Refrigerant Industry

1.2 Classification of Refrigerant

1.2.1 Type One

1.2.2 Type Two

1.2.3 Type Three

1.3 Status of Refrigerant Industry

1.3.1 Industry Overview of Refrigerant

1.3.2 Global Major Regions Status of Refrigerant

2 Industry Chain Analysis of Refrigerant

2.1 Supply Chain Relationship Analysis of Refrigerant

2.2 Upstream Major Raw Materials and Price Analysis of Refrigerant

2.3 Downstream Applications of Refrigerant

2.3.1 Application 1

2.3.2 Application 2

2.3.3 Application 3

3 Manufacturing Technology of Refrigerant

3.1 Development of Refrigerant Manufacturing Technology

3.2 Manufacturing Process Analysis of Refrigerant

3.3 Trends of Refrigerant Manufacturing Technology

4 Major Manufacturers Analysis of Refrigerant

4.1 Company 1

4.1.1 Company Profile

4.1.2 Product Picture and Specifications

4.1.3 Capacity, Production, Price, Cost, Gross and Revenue

4.1.4 Contact Information

4.2 Company 2

4.2.1 Company Profile

4.2.2 Product Picture and Specifications

4.2.3 Capacity, Production, Price, Cost, Gross and Revenue

4.2.4 Contact Information

4.3 Company 3

4.3.1 Company Profile

4.3.2 Product Picture and Specifications

4.3.3 Capacity, Production, Price, Cost, Gross and Revenue

4.3.4 Contact Information

4.4 Company 4

4.4.1 Company Profile

4.4.2 Product Picture and Specifications

4.4.3 Capacity, Production, Price, Cost, Gross and Revenue

4.4.4 Contact Information

4.5 Company 5

4.5.1 Company Profile

4.5.2 Product Picture and Specifications

4.5.3 Capacity, Production, Price, Cost, Gross and Revenue

4.5.4 Contact Information

4.6 Company 6

4.6.1 Company Profile

4.6.2 Product Picture and Specifications

4.6.3 Capacity, Production, Price, Cost, Gross and Revenue

4.6.4 Contact Information

4.7 Company 7

4.7.1 Company Profile

4.7.2 Product Picture and Specifications

4.7.3 Capacity, Production, Price, Cost, Gross and Revenue

4.7.4 Contact Information

4.8 Company 8

4.8.1 Company Profile

4.8.2 Product Picture and Specifications

4.8.3 Capacity, Production, Price, Cost, Gross and Revenue

4.8.4 Contact Information

4.9 Company 9

4.9.1 Company Profile

4.9.2 Product Picture and Specifications

4.9.3 Capacity, Production, Price, Cost, Gross and Revenue

4.9.4 Contact Information

4.10 Company ten

4.10.1 Company Profile

4.10.2 Product Picture and Specifications

4.10.3 Capacity, Production, Price, Cost, Gross and Revenue

4.10.4 Contact Information

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1294664

Continued….

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Animal Health Biotechnology Market : Key Projections about the Future State of the Global Industry

Animal Health Biotechnology Market: Overview

Biotechnology utilized in animal healthcare dates back to 19th century when the first vaccines were prepared for its use in animals. Considerable progress in the animal health biotechnology took place recently when biotechnology applications were utilized in both detecting and treating various infectious and parasitic diseases of animals. This has led to the development of a range of applications and procedures, which will benefit both domestic and wild animals. This will also improve the health of various companion animals, help in improving sporting animals’ performance and the productivity of farm animals. However, the globalised trade in live animals, animal products, and their feeds is leading to a continuously increasing threat of infectious diseases worldwide. Thus, to prevent the spread of infectious diseases, the World Organization for Animal Health (OIE) emphasizes the importance of very rapid, accurate, highly specific and sensitive detection and identification of infectious agents; and prompt and effective control of those diseases.

Obtain Report Details @ www.transparencymarketresearch.com/animal-health-biotechn…

Animal Health Biotechnology Market: Current Outlook

Presently, various reagents and diagnostic techniques have been developed, which are more specific, sensitive, rapid, reproducible and robust that have been updated through recent discoveries in biochemistry, immunology and molecular biology (monoclonal antibodies, nucleic probes, DNA amplification and others). The development of new vaccines, such as subunit vaccines, synthetic vaccines, recombinant vaccines and anti-idiotype vaccines, which combine efficacy, innocuity, duration of protection, ease of use, stability and multivalence. The availability of new anti-parasitic and anti-infective agents and immunomodulatory therapeutic agents specifies that biotechnology is continuing to find new applications in the field of animal health. These new vaccines, diagnostic techniques, and therapeutic substances will add to the knowledge, which, in future, will extend to the development of transgenic animals with improved genetic potential and will be more disease resistant and more productive at the same time. Thus, the most important objective of animal health biotechnology is to serve human healthcare as well as its environment at the same time.

Animal Health Biotechnology Market: Drivers

Major factors that will drive the demand from this market mainly includes advancements in cloning and development of transgenic animals, favorable government approval scenarios, and increasing research and development from major firms across the globe. Development of various transgenic animals and cloning will add to the animal’s ability to fight diseases and at the same time it will benefit the human society and environment. This will increase the demand for these animals; hence will contribute towards the growth of animal health biotechnology market in the future. Favorable government policies as well as supportive approval agencies will further help in the growth of this market in future. Major firms across geographies are conducting extensive R&D, which will add to the development of advanced vaccines, therapeutics as well as transgenic animals, will add to the growth of this market in future.

Fill The Form To Gain Deeper Insights On This Market @ www.transparencymarketresearch.com/sample/sample.php?flag…

Animal Health Biotechnology Market: Regional Dynamics

Geographically, North America and Europe is expected to dominate the Animal Health Biotechnology market. Major factors that will be responsible for their growth in this market can be high awareness levels of the population about cloning, transgenic products etc. and high investment in research and development activities from both public and private firms in these regions. Asia-Pacific region is also expected to show a rapid growth in this market due to availability of huge livestock population as well as dependency of various regions on animals for their daily activities. Some of the major players operating in the animal health biotechnology market are Bayer AG, Merck & Co., Inc., Pfizer, Inc., Sanofi, and Santa Cruz Biotechnology, Inc.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Animal Health Biotechnology Market : Key Projections about the Future State of the Global Industry

Animal Health Biotechnology Market: Overview

Biotechnology utilized in animal healthcare dates back to 19th century when the first vaccines were prepared for its use in animals. Considerable progress in the animal health biotechnology took place recently when biotechnology applications were utilized in both detecting and treating various infectious and parasitic diseases of animals. This has led to the development of a range of applications and procedures, which will benefit both domestic and wild animals. This will also improve the health of various companion animals, help in improving sporting animals’ performance and the productivity of farm animals. However, the globalised trade in live animals, animal products, and their feeds is leading to a continuously increasing threat of infectious diseases worldwide. Thus, to prevent the spread of infectious diseases, the World Organization for Animal Health (OIE) emphasizes the importance of very rapid, accurate, highly specific and sensitive detection and identification of infectious agents; and prompt and effective control of those diseases.

Obtain Report Details @ www.transparencymarketresearch.com/animal-health-biotechn…

Animal Health Biotechnology Market: Current Outlook

Presently, various reagents and diagnostic techniques have been developed, which are more specific, sensitive, rapid, reproducible and robust that have been updated through recent discoveries in biochemistry, immunology and molecular biology (monoclonal antibodies, nucleic probes, DNA amplification and others). The development of new vaccines, such as subunit vaccines, synthetic vaccines, recombinant vaccines and anti-idiotype vaccines, which combine efficacy, innocuity, duration of protection, ease of use, stability and multivalence. The availability of new anti-parasitic and anti-infective agents and immunomodulatory therapeutic agents specifies that biotechnology is continuing to find new applications in the field of animal health. These new vaccines, diagnostic techniques, and therapeutic substances will add to the knowledge, which, in future, will extend to the development of transgenic animals with improved genetic potential and will be more disease resistant and more productive at the same time. Thus, the most important objective of animal health biotechnology is to serve human healthcare as well as its environment at the same time.

Animal Health Biotechnology Market: Drivers

Major factors that will drive the demand from this market mainly includes advancements in cloning and development of transgenic animals, favorable government approval scenarios, and increasing research and development from major firms across the globe. Development of various transgenic animals and cloning will add to the animal’s ability to fight diseases and at the same time it will benefit the human society and environment. This will increase the demand for these animals; hence will contribute towards the growth of animal health biotechnology market in the future. Favorable government policies as well as supportive approval agencies will further help in the growth of this market in future. Major firms across geographies are conducting extensive R&D, which will add to the development of advanced vaccines, therapeutics as well as transgenic animals, will add to the growth of this market in future.

Fill The Form To Gain Deeper Insights On This Market @ www.transparencymarketresearch.com/sample/sample.php?flag…

Animal Health Biotechnology Market: Regional Dynamics

Geographically, North America and Europe is expected to dominate the Animal Health Biotechnology market. Major factors that will be responsible for their growth in this market can be high awareness levels of the population about cloning, transgenic products etc. and high investment in research and development activities from both public and private firms in these regions. Asia-Pacific region is also expected to show a rapid growth in this market due to availability of huge livestock population as well as dependency of various regions on animals for their daily activities. Some of the major players operating in the animal health biotechnology market are Bayer AG, Merck & Co., Inc., Pfizer, Inc., Sanofi, and Santa Cruz Biotechnology, Inc.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Animal Health Biotechnology Market : Key Projections about the Future State of the Global Industry

Animal Health Biotechnology Market: Overview

Biotechnology utilized in animal healthcare dates back to 19th century when the first vaccines were prepared for its use in animals. Considerable progress in the animal health biotechnology took place recently when biotechnology applications were utilized in both detecting and treating various infectious and parasitic diseases of animals. This has led to the development of a range of applications and procedures, which will benefit both domestic and wild animals. This will also improve the health of various companion animals, help in improving sporting animals’ performance and the productivity of farm animals. However, the globalised trade in live animals, animal products, and their feeds is leading to a continuously increasing threat of infectious diseases worldwide. Thus, to prevent the spread of infectious diseases, the World Organization for Animal Health (OIE) emphasizes the importance of very rapid, accurate, highly specific and sensitive detection and identification of infectious agents; and prompt and effective control of those diseases.

Obtain Report Details @ www.transparencymarketresearch.com/animal-health-biotechn…

Animal Health Biotechnology Market: Current Outlook

Presently, various reagents and diagnostic techniques have been developed, which are more specific, sensitive, rapid, reproducible and robust that have been updated through recent discoveries in biochemistry, immunology and molecular biology (monoclonal antibodies, nucleic probes, DNA amplification and others). The development of new vaccines, such as subunit vaccines, synthetic vaccines, recombinant vaccines and anti-idiotype vaccines, which combine efficacy, innocuity, duration of protection, ease of use, stability and multivalence. The availability of new anti-parasitic and anti-infective agents and immunomodulatory therapeutic agents specifies that biotechnology is continuing to find new applications in the field of animal health. These new vaccines, diagnostic techniques, and therapeutic substances will add to the knowledge, which, in future, will extend to the development of transgenic animals with improved genetic potential and will be more disease resistant and more productive at the same time. Thus, the most important objective of animal health biotechnology is to serve human healthcare as well as its environment at the same time.

Animal Health Biotechnology Market: Drivers

Major factors that will drive the demand from this market mainly includes advancements in cloning and development of transgenic animals, favorable government approval scenarios, and increasing research and development from major firms across the globe. Development of various transgenic animals and cloning will add to the animal’s ability to fight diseases and at the same time it will benefit the human society and environment. This will increase the demand for these animals; hence will contribute towards the growth of animal health biotechnology market in the future. Favorable government policies as well as supportive approval agencies will further help in the growth of this market in future. Major firms across geographies are conducting extensive R&D, which will add to the development of advanced vaccines, therapeutics as well as transgenic animals, will add to the growth of this market in future.

Fill The Form To Gain Deeper Insights On This Market @ www.transparencymarketresearch.com/sample/sample.php?flag…

Animal Health Biotechnology Market: Regional Dynamics

Geographically, North America and Europe is expected to dominate the Animal Health Biotechnology market. Major factors that will be responsible for their growth in this market can be high awareness levels of the population about cloning, transgenic products etc. and high investment in research and development activities from both public and private firms in these regions. Asia-Pacific region is also expected to show a rapid growth in this market due to availability of huge livestock population as well as dependency of various regions on animals for their daily activities. Some of the major players operating in the animal health biotechnology market are Bayer AG, Merck & Co., Inc., Pfizer, Inc., Sanofi, and Santa Cruz Biotechnology, Inc.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Department Stores 2017 Global Market Challenge, Key Players, Trends & Forecast to 2021

Department Stores Market 2017 Share, Trend, Segmentation and Forecast to 2020

PUNE, INDIA, May 22, 2017 /EINPresswire.com/ — Summary
Global department store retail market is expected to grow at a CAGR of 5.4% during 2015–2020, driven by the rising purchasing power of the middle-class population, young working professionals, and the expansion of department stores in emerging markets. Off-price department store sales are growing positively in North America, and the format is expected to gain popularity in Europe in the future. In an effort to provide a seamless shopping experience to the customers, department store retailers are developing new innovative concepts such as virtual reality, augmented reality, and others.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/768586-global-department-stores-retailing-2015-2020

Key Findings
– Global department store sales are forecast to reach US$675.9 billion by 2020, with major impetus from developing economies
– Clothing and footwear remained the most preferred category through the channel
– Shoppers seeking discounts and savings are driving sales in off-price department stores
– Indonesia will grow the fastest during the forecast period, followed by India and Philippines
– Despite a slow growth in the US, the market will continue to be the largest market in 2020

Synopsis
– Provides a comprehensive view of the global department stores retail landscape, including current market sizes and category forecasts to 2020; and highlights the world’s fastest growing markets and category groups
– Details market size and category forecasts for each region and countries, and features major retailers, key innovative retailers, and department store retail trends
– The report covers the 50 largest retail markets and includes 24 countries in Europe, 12 countries in Asia-Pacific, nine countries in the Americas, and five countries in the Middle East and Africa

Reasons to Buy
– The report provides an essential overview of the global department stores retail market, highlighting the largest and fastest-growing markets across the globe
– Provides analysis of the latest trends, market dynamics (covering nine category groups) and key innovations in the retail space in major countries across the four regions
– Identify the largest and fastest-growing categories in major countries across the four regions
– Benefit from detailed analysis of key trends influencing the department store retail market.
– Monitor the competitive landscape, with analysis of key players across the four regions, including market share of the retailers for the region

Table of Contents
Highlights
Global Department Stores Retailing, 2015–2020
Executive Summary
Global Department Stores Retailing
The market
Category Analysis
Trends
Key department store retailers
Department stores retailing in the Americas – The market, category analysis and trends
Major retailers and retail innovations in the Americas
Department stores retailing in Europe – The market, category analysis and trends
Major retailers and retail innovations in Europe
Department stores retailing in Asia-Pacific – The market, category analysis and trends
Major retailers and retail innovations in Asia-Pacifi
Department stores retailing in the Middle East and Africa – The market, category analysis and trends
Major retailers and retail innovations in the Middle East and Africa
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/768586-global-department-stores-retailing-2015-2020

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here

Department Stores 2017 Global Market Challenge, Key Players, Trends & Forecast to 2021

Department Stores Market 2017 Share, Trend, Segmentation and Forecast to 2020

PUNE, INDIA, May 22, 2017 /EINPresswire.com/ — Summary
Global department store retail market is expected to grow at a CAGR of 5.4% during 2015–2020, driven by the rising purchasing power of the middle-class population, young working professionals, and the expansion of department stores in emerging markets. Off-price department store sales are growing positively in North America, and the format is expected to gain popularity in Europe in the future. In an effort to provide a seamless shopping experience to the customers, department store retailers are developing new innovative concepts such as virtual reality, augmented reality, and others.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/768586-global-department-stores-retailing-2015-2020

Key Findings
– Global department store sales are forecast to reach US$675.9 billion by 2020, with major impetus from developing economies
– Clothing and footwear remained the most preferred category through the channel
– Shoppers seeking discounts and savings are driving sales in off-price department stores
– Indonesia will grow the fastest during the forecast period, followed by India and Philippines
– Despite a slow growth in the US, the market will continue to be the largest market in 2020

Synopsis
– Provides a comprehensive view of the global department stores retail landscape, including current market sizes and category forecasts to 2020; and highlights the world’s fastest growing markets and category groups
– Details market size and category forecasts for each region and countries, and features major retailers, key innovative retailers, and department store retail trends
– The report covers the 50 largest retail markets and includes 24 countries in Europe, 12 countries in Asia-Pacific, nine countries in the Americas, and five countries in the Middle East and Africa

Reasons to Buy
– The report provides an essential overview of the global department stores retail market, highlighting the largest and fastest-growing markets across the globe
– Provides analysis of the latest trends, market dynamics (covering nine category groups) and key innovations in the retail space in major countries across the four regions
– Identify the largest and fastest-growing categories in major countries across the four regions
– Benefit from detailed analysis of key trends influencing the department store retail market.
– Monitor the competitive landscape, with analysis of key players across the four regions, including market share of the retailers for the region

Table of Contents
Highlights
Global Department Stores Retailing, 2015–2020
Executive Summary
Global Department Stores Retailing
The market
Category Analysis
Trends
Key department store retailers
Department stores retailing in the Americas – The market, category analysis and trends
Major retailers and retail innovations in the Americas
Department stores retailing in Europe – The market, category analysis and trends
Major retailers and retail innovations in Europe
Department stores retailing in Asia-Pacific – The market, category analysis and trends
Major retailers and retail innovations in Asia-Pacifi
Department stores retailing in the Middle East and Africa – The market, category analysis and trends
Major retailers and retail innovations in the Middle East and Africa
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/768586-global-department-stores-retailing-2015-2020

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here

Ossur Hf : Share options granted

Announcement from Össur hf. No.39/2017Reykjavik, 22 May 2017 

Today, Össur hf. has granted 125,000 share options to middle management. The exercise price is DKK 26.66, i.e. the Company’s average share price on NASDAQ Copenhagen 20 trading days prior to the grant date. First exercise date is 22 May 2020. The share options were granted in accordance with the Company’s share option scheme implemented on 27 May 2015. Further details on the share option scheme, including the key terms and conditions, can be found in the Company’s announcement No. 24/2015 published on 27 May 2015. Össur press releases by e-mail: If you wish to receive Össur press releases by e-mail please register at the following web-site: http://www.ossur.com/investormailings.About Össur Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of braces, supports and prosthetic limbs. A recognized „Technology Pioneer”, Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.comForward-Looking Statements This press release includes „forward-looking statements” which involve risks and uncertainties that could cause actual results to differ materially from results expressed or implied by these statements. Össur hf. undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement. 

Ossur Hf : Share options granted

Announcement from Össur hf. No.39/2017Reykjavik, 22 May 2017 

Today, Össur hf. has granted 125,000 share options to middle management. The exercise price is DKK 26.66, i.e. the Company’s average share price on NASDAQ Copenhagen 20 trading days prior to the grant date. First exercise date is 22 May 2020. The share options were granted in accordance with the Company’s share option scheme implemented on 27 May 2015. Further details on the share option scheme, including the key terms and conditions, can be found in the Company’s announcement No. 24/2015 published on 27 May 2015. Össur press releases by e-mail: If you wish to receive Össur press releases by e-mail please register at the following web-site: http://www.ossur.com/investormailings.About Össur Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of braces, supports and prosthetic limbs. A recognized „Technology Pioneer”, Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.comForward-Looking Statements This press release includes „forward-looking statements” which involve risks and uncertainties that could cause actual results to differ materially from results expressed or implied by these statements. Össur hf. undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement. 

Research Reports Initiated on Financials Stocks: Sprott, Tricon Capital Group, Noranda Income Fund, and Canoe EIT Income Fund

LONDON, UK / ACCESSWIRE / May 22, 2017 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Asset Management industry. Companies recently under review include Sprott, Tricon Capital Group, Noranda Income Fund, and Canoe EIT Income Fund. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

At the close of the Canadian markets on Friday, May 19, 2017, the Toronto Exchange Composite index ended the trading session at 15,458.46, 1.19% higher from its previous closing price.

The Financials Index was also in the black, closing the day at 277.86, up 0.95%.

Active Wall St. has initiated research reports on the following equities: Sprott Inc. (TSX: SII), Tricon Capital Group Inc. (TSX: TCN), Noranda Income Fund (TSX: NIF-UN), and Canoe EIT Income Fund (TSX: EIT-UN). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Sprott Inc.

Toronto, Canada-based Sprott Inc.’s stock edged 0.82% higher, to finish Friday’s session at $2.45 with a total volume of 132,775 shares traded. Over the last one month and the previous three months, Sprott’s shares have gained 9.87% and 6.06%, respectively. However, the stock has fallen by 0.41% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. Sprott’s 200-day moving average of $2.35 is above its 50-day moving average of $2.29. Shares of the Company, which through its subsidiaries, the firm provides asset management, portfolio management, wealth management, fund management, and administrative and consulting services to its clients, are trading at a PE ratio of 16.67. See our research report on SII.TO at:

http://www.activewallst.com/register/

Tricon Capital Group Inc.

On Friday, shares in Toronto, Canada-based Tricon Capital Group Inc. recorded a trading volume of 298,892 shares, which was above their three months average volume of 287,406 shares. The stock ended the day 1.74% higher at $11.10. Tricon Capital’s stock has advanced 0.91% in the last one month and 4.62% in the previous three months. Furthermore, the stock has gained 28.62% in the previous one year. The Company’s shares are trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $10.92 is above its 200-day moving average of $10.15. Shares of the Company, which owns and manages on behalf of third-party investors a portfolio of investments in land and homebuilding assets, single-family rental homes, manufactured housing communities, and multi-family development projects, are trading at a PE ratio of 26.06. The complimentary research report on TCN.TO at:

http://www.activewallst.com/register/

Noranda Income Fund

On Friday, shares in Noranda Income Fund ended the session flat at $1.48 with a total volume of 39,396 shares traded. Shares of the Company, which owns an electrolytic zinc processing facility and ancillary assets located in Salaberry-de-Valleyfield, Quebec, are trading below its 50-day and 200-day moving averages. Furthermore, the stock’s 200-day moving average of $2.13 is greater than its 50-day moving average of $1.57. Register for free and access the latest research report on NIF-UN.TO at:

http://www.activewallst.com/register/

Canoe EIT Income Fund

Canada-domiciled Canoe EIT Income Fund’s stock closed the day 0.50% higher at $12.05. The stock recorded a trading volume of 80,880 shares. Canoe EIT Income Fund’s shares have advanced 0.67% in the last one month and 0.50% in the past three months. The company’s shares are trading above their 50-day moving average. Moreover, the stock’s 200-day moving average of $12.09 is greater than its 50-day moving average of $12.01. Shares of Canoe EIT Income, which invests in the public equity and fixed income markets of Canada and the US, are trading at a PE ratio of 5.78. Get free access to your research report on EIT-UN.TO at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the „Author”) and is fact checked and reviewed by a third party research service company (the „Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the „Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: [email protected]

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

Research Reports Initiated on Financials Stocks: Sprott, Tricon Capital Group, Noranda Income Fund, and Canoe EIT Income Fund

LONDON, UK / ACCESSWIRE / May 22, 2017 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Asset Management industry. Companies recently under review include Sprott, Tricon Capital Group, Noranda Income Fund, and Canoe EIT Income Fund. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

At the close of the Canadian markets on Friday, May 19, 2017, the Toronto Exchange Composite index ended the trading session at 15,458.46, 1.19% higher from its previous closing price.

The Financials Index was also in the black, closing the day at 277.86, up 0.95%.

Active Wall St. has initiated research reports on the following equities: Sprott Inc. (TSX: SII), Tricon Capital Group Inc. (TSX: TCN), Noranda Income Fund (TSX: NIF-UN), and Canoe EIT Income Fund (TSX: EIT-UN). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Sprott Inc.

Toronto, Canada-based Sprott Inc.’s stock edged 0.82% higher, to finish Friday’s session at $2.45 with a total volume of 132,775 shares traded. Over the last one month and the previous three months, Sprott’s shares have gained 9.87% and 6.06%, respectively. However, the stock has fallen by 0.41% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. Sprott’s 200-day moving average of $2.35 is above its 50-day moving average of $2.29. Shares of the Company, which through its subsidiaries, the firm provides asset management, portfolio management, wealth management, fund management, and administrative and consulting services to its clients, are trading at a PE ratio of 16.67. See our research report on SII.TO at:

http://www.activewallst.com/register/

Tricon Capital Group Inc.

On Friday, shares in Toronto, Canada-based Tricon Capital Group Inc. recorded a trading volume of 298,892 shares, which was above their three months average volume of 287,406 shares. The stock ended the day 1.74% higher at $11.10. Tricon Capital’s stock has advanced 0.91% in the last one month and 4.62% in the previous three months. Furthermore, the stock has gained 28.62% in the previous one year. The Company’s shares are trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $10.92 is above its 200-day moving average of $10.15. Shares of the Company, which owns and manages on behalf of third-party investors a portfolio of investments in land and homebuilding assets, single-family rental homes, manufactured housing communities, and multi-family development projects, are trading at a PE ratio of 26.06. The complimentary research report on TCN.TO at:

http://www.activewallst.com/register/

Noranda Income Fund

On Friday, shares in Noranda Income Fund ended the session flat at $1.48 with a total volume of 39,396 shares traded. Shares of the Company, which owns an electrolytic zinc processing facility and ancillary assets located in Salaberry-de-Valleyfield, Quebec, are trading below its 50-day and 200-day moving averages. Furthermore, the stock’s 200-day moving average of $2.13 is greater than its 50-day moving average of $1.57. Register for free and access the latest research report on NIF-UN.TO at:

http://www.activewallst.com/register/

Canoe EIT Income Fund

Canada-domiciled Canoe EIT Income Fund’s stock closed the day 0.50% higher at $12.05. The stock recorded a trading volume of 80,880 shares. Canoe EIT Income Fund’s shares have advanced 0.67% in the last one month and 0.50% in the past three months. The company’s shares are trading above their 50-day moving average. Moreover, the stock’s 200-day moving average of $12.09 is greater than its 50-day moving average of $12.01. Shares of Canoe EIT Income, which invests in the public equity and fixed income markets of Canada and the US, are trading at a PE ratio of 5.78. Get free access to your research report on EIT-UN.TO at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the „Author”) and is fact checked and reviewed by a third party research service company (the „Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the „Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: [email protected]

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street